Document:

sonm-ex102_441.htm

Exhibit 10.2

September 9, 2019

Mr. Robert Tirva

Via E-mail

Re: Employment Agreement

Dear Bob:

This letter agreement (the “Agreement”) confirms the terms of your employment with Sonim Technologies, Inc. (the “Company” or “Sonim”). 

1.Position and Duties. Beginning on September 9, 2019 (your “Start Date”), you will serve as the Company’s Interim Chief Financial Officer (the “Interim CFO”), reporting to the Company’s President and Chief Executive Officer (the “CEO”). You will work at our facility located in San Mateo, California. Of course, Sonim may change your position, duties, and work location from time to time, as it deems necessary. You will devote your full business time and attention to the business affairs of the Company, except for reasonable vacations and periods of illness or incapacity. As a Sonim employee, you will be expected to abide by Company rules and policies and to acknowledge in writing that you have read the Company’s Employee handbook.

2.Compensation and Benefits.

(a)Base Salary. You will receive a base salary of $300,000 per year, less required and designated payroll deductions and withholdings, and payable according to the Company’s regular payroll schedule.  Your annual base salary will be reviewed from time to time and is subject to change at the discretion of the Compensation Committee of the Company’s Board of Directors. 

(b)Benefits. You will be eligible to participate in the Company’s standard employee benefits pursuant to the terms, conditions and limitations of the applicable benefit plans. In the event of the consummation of a Change in Control, the Company will use its reasonable best efforts to ensure that the benefits provided to you following the Change in Control (assuming your employment continues) will be equal to or greater than the benefits provided to you as of the date of this Agreement. 

(c)Cash Bonus Plan. As a member of senior management of the Company, you will be eligible to participate under the Company’s Cash Bonus Plan, the current terms of which are set forth on Exhibit A attached hereto.  Notwithstanding the terms of the Company’s Cash Bonus Plan that require your continued employment through the determination date of payment of an earned cash bonus, in the event that the Company terminates your employment for any reason other than for Cause (as defined herein), or your employment terminates due to your death or permanent disability, or you resign for Good Reason, you will be entitled to receive a pro-rata payment of your Target Bonus for the year of your termination based on the number of months of your employment during the applicable bonus year and based on full achievement of the EBITDA target under the Cash Bonus Plan. 

(d)Equity Incentive Compensation.  Subject to approval by the Board, you will receive a target number of option equivalents valued at $652,200, split 50/50 between options (the “Options”) and restricted stock units (“RSUs”) with the final allocation to be determined by Radford, the Company’s outside compensation consultant. The RSUs and Options shall be subject to the terms and conditions of the Company’s 2019Equity Incentive Plan, any amendments thereto, (the “Plan”) and the applicable grant notice and award agreement.  The Options shall vest with respect to 25% of the shares on 

 

		
	
September 9, 2019

Page 2
	
 

 

the one year anniversary of the Start Date and the remainder of the shares shall vest with respect to 1/48 of the shares in equal monthly installments thereafter, subject to your continued service to the Company.  The RSUs shall vest in equal yearly installments on each of the first, second, third and fourth anniversaries of your Start Date, subject to your continued service to the Company. 

3.Proprietary Information Agreement and Company Policies. As a condition of your employment, you must sign and abide by the Company’s standard form of Employment, Confidential Information and Invention Assignment Agreement (the “Proprietary Information Agreement”), a copy of which is attached hereto as Exhibit B. In your work for the Company, you will be expected not to use or disclose any confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of confidentiality.  Rather, you will be expected to use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company.  You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation of confidentiality.  You hereby represent that your employment does not create a conflict with any agreement between you and a third-party.

4.No Conflicts. During the term of your employment with the Company, except on behalf of the Company, you agree not to directly or indirectly, whether as an officer, director, employee, stockholder, partner, proprietor, associate, representative, consultant, agent, or in any capacity whatsoever, engage in, become financially interested in, be employed by or have any business connection with any other person, corporation, firm, partnership or other entity whatsoever which is known by you to compete directly with the Company, throughout the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that you may own, as a passive investor, securities of any publicly-held competitor corporation, so long as your direct holdings in any one such corporation shall not in the aggregate constitute more than 1% of the voting stock of such corporation.

5.At-Will Employment Relationship. Your employment relationship is at will, meaning either you or the Company may terminate your employment relationship at any time, with or without Cause, and with or without advance notice. In addition, the Company may modify the other terms and conditions of your employment, including, but not limited to, compensation, benefits, position, title, reporting relationship and office location, from time to time in its sole discretion. Your at-will employment relationship can only be changed in a written agreement signed by you and the CEO or by a duly authorized member of the Board.

6.Severance Benefits.

(a)Termination by the Company without Cause; Termination Due to Death or Disability; or Resignation for Good Reason Within 90 Days of Your Start Date.  If at any time prior to the 90th day following the Start Date (the “Interim Period”), the Company terminates your employment without Cause, or your employment terminates due to your death or permanent disability, or you resign for Good Reason, and provided such termination constitutes a “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from Service”), then subject to your obligations below, the Company will provide you the following severance benefits:

(i)the Company will make severance payments to you in the form of salary continuation payments for a period of two (2) months at the rate of your base salary in effect as of your termination date, less required and designated payroll deductions and withholdings;

 

		
	
September 9, 2019

Page 3
	
 

 

(ii)the vesting of the outstanding Options and RSUs as of your termination date shall be accelerated such that 1/48th of each (i.e. 1/48th of the Options and 1/48th of the RSUs) will be deemed vested for each full month you served as Interim CFO, as of your termination date.

(iii)For purposes of clarity, if you receive severance benefits under this section 6(a), you shall not be eligible for severance benefits under section 6(b) or 6(c). 

(b)Termination by the Company without Cause; Termination Due to Death or Disability or Resignation for Good Reason Prior to a Change in Control and After the Interim Period. If at any time prior to a Change in Control, or more than thirteen (13) months after a Change in Control, the Company terminates your employment without Cause, or your employment terminates due to your death or permanent disability, or you resign for Good Reason, and provided such termination constitutes a Separation from Service, and if such termination occurs following expiration of the Interim Period, then subject to your obligations below, the Company will provide you the following severance benefits: 

(i)the Company will make severance payments to you in the form of salary continuation payments for a period of nine (9) months at the rate of your base salary in effect as of your termination date, less required and designated payroll deductions and withholdings; and

(ii)if you timely elect continued health insurance coverage under COBRA, the Company will reimburse you the cost of your COBRA premiums to continue your coverage (including coverage for eligible dependents, if applicable) (“COBRA Premiums”) through the period (the “COBRA Premium Period”) starting on the Separation Date and ending on the earliest to occur of: (x) nine (9) months after your termination (y) the date you become eligible for group health insurance coverage through a new employer; or (z) the date you cease to be eligible for COBRA continuation coverage for any reason, including plan termination. In the event you become covered under another employer's group health plan or otherwise cease to be eligible for COBRA during the COBRA Premium Period, you must immediately notify the Company in writing of such event.

(iii)For purposes of clarity, if you receive severance benefits under this section 6(b), you shall not be eligible for severance benefits under section 6(a) or 6(c).

(c)Termination by the Company without Cause or Resignation for Good Reason Following a Change in Control and After the Interim Period. If at any time within thirteen (13) months after a Change in Control, the Company terminates your employment without Cause, or you resign for Good Reason, and provided such termination constitutes a Separation from Service, and if such termination occurs following expiration of the Interim Period, then subject to your obligations below, the Company will provide you with the following severance benefits:

(i)the Company will make severance payments to you in the form of salary continuation payments for a period of twelve (12) months at the rate of your base salary in effect as of your termination date, less required and designated payroll deductions and withholdings;

(ii)if you timely elect continued health insurance coverage under COBRA, the Company will reimburse you for your COBRA Premiums through the period (the “CIC COBRA Premium Period”) starting on the Separation Date and ending on the earliest to occur of: (x) twelve (12) months after your termination (y) the date you become eligible for group health insurance coverage through a new employer; or (z) the date you cease to be eligible for COBRA continuation coverage for any reason, including plan termination. In the event you become covered under another employer's group health plan 

 

		
	
September 9, 2019

Page 4
	
 

 

or otherwise cease to be eligible for COBRA during the CIC COBRA Premium Period, you must immediately notify the Company in writing of such event; and

(iii)the vesting of any then-outstanding stock options/awards as of your termination date shall be accelerated in full as of your termination date.

(iv)For purposes of clarity, if you receive severance benefits under this section 6(c), you shall not be eligible for severance benefits under section 6(a) or 6(b).

(d)The severance benefits described above are conditional upon (a) your continuing to comply with your obligations under your Proprietary Information Agreement; and (b) your delivering to the Company an effective, general release of claims in favor of the Company in a form acceptable to the Company within 30 days following your Separation from Service. The salary continuation payments will be paid in equal installments on the Company’s regular payroll schedule and will be subject to applicable tax withholdings over the period outlined above following the date of your Separation from Service; provided, however, that no payments will be made prior to the 30th day following your Separation from Service. On the 30th day following your Separation from Service, the Company will pay you in a lump sum the salary continuation payments that you would have received on or prior to such date under the original schedule but for the delay while waiting for the 30th day in compliance with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the effectiveness of the release, with the balance of the salary continuation payments being paid as originally scheduled.

7.Definitions.

(a)Cause. For purposes of this Agreement, “Cause” is defined as any of the following: (i) theft, dishonesty, or falsification of any employment or Company record; (ii) conviction (including any plea of guilty or nolo contendere) of a felony or any criminal act that impairs your ability to perform your duties with the Company; (iii) failure or inability to perform any reasonable assigned duties after notice from the Company of, and a reasonable opportunity to cure, such failure or inability, if capable of cure; (iv) improper disclosure of the Company’s confidential or proprietary information; (v) commission of an intentional or grossly negligent act that has a material detrimental effect on the Company’s reputation or business; or (vi) any material breach of any written agreement with the Company, which breach is not cured pursuant to the terms of such agreement, if capable of cure, or a material breach of a confidentiality or proprietary information and inventions agreement, which breach shall be deemed non-curable.

(b)Change in Control. For purposes of this Agreement, the definition of a “Change in Control” is as defined in section 13(i) of the Company’s 2019 Equity Incentive Plan. 

(c)Good Reason. For purposes of this Agreement, you will have “Good Reason” for your resignation from your employment with the Company if any of the following actions are taken by the Company without your express written consent:

(i)any failure by the Company to pay, or any material reduction by the Company of (a) your base salary in effect immediately prior to such failure to pay or reduction (unless reductions comparable in amount and duration are concurrently made generally for employees of the Company with responsibilities, organizational level and title comparable to your own), or (b) your bonus compensation amount eligibility, if any, in effect immediately prior to the date of such failure to pay or such reduction (subject to applicable performance requirements with respect to the actual amount of bonus compensation you earn);

 

		
	
September 9, 2019

Page 5
	
 

 

(ii)the assignment of any duties, or the reduction of your responsibilities or duties, that are materially inconsistent with your position, duties, responsibilities and status with the Company immediately prior to such assignment or reduction; provided, however, that your assignment to an operating division of an acquiring company that includes the business of the Company following an acquisition, pursuant to which your duties are commensurate with the duties you had before the acquisition, except that the business of the Company is no longer independent but contained in a division, shall not be deemed a material reduction of your responsibilities, duties, or status hereunder and your resignation in connection therewith shall not be deemed for “Good Reason;” 

(iii)the relocation of your principal place of employment to a location that is more than fifty (50) miles from the County of San Mateo in the State of California;

provided, however, that to resign for Good Reason, you must (1) provide written notice to the CEO within 30 days after the first occurrence of the event giving rise to Good Reason setting forth the basis for your resignation, (2) allow the Company at least 30 days from receipt of such written notice to cure such event, and (3) if such event is not reasonably cured within such period, your resignation from all positions you then hold with the Company is effective not later than 90 days after the expiration of the cure period

8.Code Section 409A. It is intended that all of the benefits and payments under this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Code Section 409A provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9), and this Agreement will be construed to the greatest extent possible as consistent with those provisions. If not so exempt, this Agreement (and any definitions hereunder) will be construed in a manner that complies with Code Section 409A and incorporates by reference all required definitions and payment terms. For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), your right to receive any installment payments under this Agreement (whether severance payments, reimbursements or otherwise) will be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder will at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Agreement, if you are deemed by the Company at the time of your Separation from Service to be a “specified employee” for purposes of Code Section 409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or under any other agreement with the Company are deemed to be “deferred compensation”, then if delayed commencement of any portion of such payments is required to avoid a prohibited distribution under Code Section 409A(a)(2)(B)(i) and the related adverse taxation under Section 409A, the timing of the payments upon a Separation from Service will be delayed as follows: on the earlier to occur of (i) the date that is six months and one day after the effective date of your Separation from Service, and (ii) the date of the your death (such earlier date, the “Delayed Initial Payment Date”), the Company will (A) pay to you a lump sum amount equal to the sum of the payments upon Separation from Service that you would otherwise have received through the Delayed Initial Payment Date if the commencement of the payments had not been delayed pursuant to this paragraph, and (B) commence paying the balance of the payments in accordance with the applicable payment schedules set forth above. No interest will be due on any amounts so deferred.

9.Entire Agreement. This Agreement, including Exhibit A and Exhibit B, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with respect to the terms and conditions of your employment. If you enter into this Agreement, you are doing so voluntarily, and without reliance on any promise, warranty, representation or agreement, written or oral, other than those expressly contained herein. This Agreement supersedes any and all promises, warranties, representations or agreements, whether oral or written, including the Offer Letter. This Agreement may not 

 

		
	
September 9, 2019

Page 6
	
 

 

be amended or modified except by a written instrument signed by you and a duly authorized member of the Board.

10.Enforceability. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement, and the Agreement, including the invalid or unenforceable provisions, shall be enforced insofar as possible to achieve the intent of the parties.

11.Binding Nature. This Agreement will be binding upon and inure to the benefit of the personal representatives and successors of the respective parties hereto.

12.Governing Law. This Agreement will be governed by and construed in accordance with the laws of the State of California without regard to conflicts of law principles.

13.Miscellaneous. With respect to the enforcement of this Agreement, no waiver of any right hereunder shall be effective unless it is in writing. For purposes of construction of this Agreement, any ambiguity shall not be construed against either party as the drafter. This Agreement may be executed in more than one counterpart, and signatures transmitted via facsimile shall be deemed equivalent to originals.

 

		
	
September 9, 2019

Page 7
	
 

 

 

If these revised terms of your employment with Sonim are acceptable to you, please sign this Agreement and return it to me.

Sincerely,
Sonim Technologies, Inc.

/s/ Robert J. Plaschke

Robert J. Plaschke
Chief Executive Officer 

Understood and agreed to:

/s/ Robert Tirva
Robert Tirva
Interim Chief Financial Officer

September 11, 2019
Date

 

 

 

EXHIBIT A: CASH BONUS PLAN

	
A.
	
Subject to the discretion of the Board of Directors of the Company (the “Board”), you will be eligible for an annual Bonus that will be based upon the “EBITDA” (as defined below) performance of the Company and the following guidelines:

			
	
Year
	
Target Bonus
	
EBITDA Target

	
2019

2020, beyond
	
50% of Annual Salary

50% of Annual Salary
	
$10,484,000

To Be Determined

“EBITDA” is defined as:

	
 
	
•
	
Operating Profit

	
 
	
•
	
Add back: depreciation, amortization, interest and taxes

	
 
	
•
	
Less: all cash disbursements due employees under the Cash Bonus Plan for the current year

	
B.
	
The Board will determine the actual bonus to which you are entitled each year using a formula mutually agreed upon at the beginning of each year.

	
C.
	
The Company’s EBITDA for each year shall be approved by the Board as soon as practicable following completion of the respective year-end audit (the date of such determination, the “Determination Date”). The Company’s EBITDA targets for 2020 and beyond will be approved by the Board annually, which approval is expected to occur prior to January 31 each year.  The Company’s EBITDA result for a year in which a Change in Control occurs shall be determined without taking into consideration any costs associated with the Change in Control that affect the Company’s financial results for that year. 

	
D.
	
If approved, bonus payments will be made annually and in accordance with Company’s standard policies and procedures. Payment shall be conditioned on (1) you being in the Company’s continuous service through the relevant year’s Determination Date and (2) Sonim maintaining an agreed upon minimum cash balance at the end of the fiscal quarter immediately preceding the respective Determination Date. In the event any approved bonus amounts are not paid pursuant to the foregoing subsection (2), such amounts shall be paid to you when and if Sonim achieves the cash balance, at which time you must be in the Company’s continuous service to earn and receive such bonus payment.

 

 

EXHIBIT B: PROPRIETARY INFORMATION AGREEMENTBlueprint

 

Exhibit
10.1

AMENDMENT 1 TO PURCHASE AND SALE AGREEMENT

 

THIS
AMENDMENT 1 to PURCHASE AND SALE AGREEMENT (the "Agreement") is made as of October 23,
2019 (the "Effective Date"),
by and among GrowLife, Inc., a Delaware corporation ("Buyer") on the one hand, and
EZ Clone Enterprises, Inc.,
a California corporation (the "Company"), Brad Mickelsen, individually
and in his capacity as a shareholder ("Mr. Mickelsen") and William Blackburn,
individually and in his capacity as a shareholder ("Mr. Blackburn") Mr. Mickelsen and Mr.
Blackburn sometimes individually referred to as a "Seller" and collectively as the
"Sellers." The Buyer and
Sellers may hereinafter be referred independently as "Party" or collectively as the
"Parties". All capitalized
terms used but not otherwise defined herein shall have the meanings
ascribed to them in the PSA (as defined below).

 

 

RECITALS

 

WHEREAS, the Parties entered into
PURCHASE AND SALE AGREEMENT dated October 10, 2018
(“PSA”);

 

WHEREAS, the Parties now wish to
formally amend and modify the PSA by this Agreement;

 

WHEREAS, this Agreement has been signed
by the Parties for their mutual benefit and to accurately reflect
the proper terms and conditions of the PSA and this
Agreement;

 

WHEREAS, by this Agreement, the Parties
intend for this Agreement to properly amend the underlying PSA so
that it supersedes and replaces all prior and contemporaneous
agreements and understandings, oral and written, with regard to
such provisions amended by this Agreement.

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual
representations, warranties, covenants and agreements contained in
this Agreement, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the
Parties hereto, intending to be legally bound hereby, agree as
follows:

 

AGREEMENT

 

1.

Recitals. The
foregoing recitals are true and correct in all material respects
and are hereby incorporated herein as a material part of this
Addendum.

 

2. 

Amendment
to PSA;
Consideration.

 

Section
1.02 of the PSA is hereby revoked, repealed, and replaced in its
entirety with the following:

 

“1.02.    
Purchase and Sale of
Shares at Second Closing. Subject to completion of the First
Closing, Buyer shall have the obligation to acquire the remaining
forty–nine percent (49%) ownership interest in Seller for a
period a period of (9) nine months after October 16, 2019, within
which to acquire the remaining forty-nine (49%) percent, as
follows:

 

(a)           
On the terms and subject to the conditions set forth in this
Agreement, at the Second Closing, the Sellers will sell, transfer
and deliver to Buyer, and Buyer will purchase and accept from the
Sellers, all of the Sellers' rights, title and interest in and to
the remaining Shares held by the Sellers as identified on
Schedule 1.02 to
PSA (the "Second Closing
Shares"), free and clear of any any liens, claims, charges,
restrictions, obligations, and encumbrances.

 

(b)           
In consideration for the sale and
delivery to Buyer of the Second Closing Shares at the Second
Closing, Buyer agrees to pay to the Sellers an aggregate purchase
price of One Million Nine Hundred Sixty Thousand Even Dollars
($1,960,000) payable as follows: (i) a cash payment equal to Eight
Hundred Fifty–Five Thousand Even Dollars ($855,000) to be
allocated in the form and amounts as set forth in Schedule 1.02 to
PSA; and (ii) Eighty – Five Million (85,000,000) shares of
Buyer’s common stock, at a price of 0.013 per share, which
equates to an aggregate value of One Million One Hundred Five
Thousand Even Dollars ($1,105,000) (collectively, the
"Second
Closing Purchase Price") in the
form and amounts as are set forth on Schedule 1.02
to PSA.

 

(c)
Buyer agrees to pay a 20% cash extension. The fee is payable at the
earlier of 30 days from the closing of a funding of $2,000,000 or
more, or at the closing of Traunch 2, whichever is sooner. Thus,
20% of $855,000 or $171,000 is due to both Sellers in total as
consideration for this Agreement.”

 

              (d)
The Parties agree that if any other terms are reached with Brad
Mickelsen, William Blackburn will be offered the same terms, other
than any consulting fee.

 

 

 

 

3. Full Force and Effect of Other Terms. The Parties hereby confirm that all
other terms and conditions of the PSA are in full force and effect
and are un-amended except as expressly provided in this
Agreement.

 

4. Counterparts. This
Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall
constitute one and the same agreement.

 

5. Electronic Signatures. The Parties agree that any form of
electronic signature, including but not limited to signatures via
facsimile, scanning, or electronic mail, may substitute for the
original signature and shall have the same legal effect as the
original signature.

 

 

[Remainder of page intentionally left blank; signatures appear on
following page]

SIGNATURE PAGE TO AMENDMENT 1 to STOCK PURCHASE
AGREEMENT

 

 

IN
WITNESS WHEREOF, each of the parties hereto has executed this
Agreement as of the date first set forth above.

 

BUYER

 

GROWLIFE
INC.

 

                                                                                       /s/
Marco Hegyi

 

By:
Marco Hegyi

Title:
President & CEO

 

COMPANY

 

EZ
CLONE ENTERPRISES, INC.

 

 

By:
William Blackburn

 

Title: President

 

SELLERS

 

 

Brad
Mickelsen

 

                                                                                       /s/
William Blackburn

 

 

William
Blackburn

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}]]